Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-056912
Filing Date
2023-11-29
Accepted
2023-11-29 16:46:04
Documents
2
Period of Report
2023-11-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2163
2 POA DOCUMENT poa.txt EX-24 3072
  Complete submission text file 0001209191-23-056912.txt   6694
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address
Lee Jacks (Reporting) CIK: 0001935943 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39323 | Film No.: 231452964